Cargando…
Alpha‐2‐Heremans‐Schmid‐glycoprotein (AHSG) a potential biomarker associated with prognosis of chromophobe renal cell carcinoma: The PROPOLIS study
BACKGROUND AND AIMS: Chromophobe renal cell carcinoma (chRCC) is the third common pathological subtype in renal cancers. However, the underlying mechanisms of specific genetic characteristics of chRCC are currently unclear. In this study, protein expression profiles, gene ontology (GO), and survival...
Autores principales: | Li, Xin, Ma, Cuiyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9576116/ https://www.ncbi.nlm.nih.gov/pubmed/36262809 http://dx.doi.org/10.1002/hsr2.878 |
Ejemplares similares
-
The α2-HeremansSchmid glycoprotein (AHSG) promotes growth in head and neck squamous cell carcinoma (HNSCC)
por: Thompson, Pamela D, et al.
Publicado: (2013) -
Alpha-2 Heremans Schmid Glycoprotein (AHSG) promotes the proliferation of bladder cancer cells by regulating the TGF-β signalling pathway
por: Dong, Yufei, et al.
Publicado: (2022) -
Genetic Variation of the Human α-2-Heremans-Schmid Glycoprotein
(AHSG) Gene Associated with the Risk of SARS-CoV Infection
por: Zhu, Xiaohui, et al.
Publicado: (2011) -
α2-Heremans-schmid glycoprotein (fetuin A) downregulation and its utility in inflammatory bowel disease
por: Manolakis, Anastassios C, et al.
Publicado: (2017) -
There is No Association between Premature Ovarian Insufficiency and Levels of Fetuin-A/α2-Heremans-Schmid Glycoprotein
por: Ozgu-Erdinc, A. Seval, et al.
Publicado: (2019)